Progressive disease
A prediction model for progressive disease in systemic sclerosis
... of progressive disease is available, and therefore overall progressive disease was de fi ned as a combination of MIDs as used in rando- mised clinical trials in ...
9
The mode of progressive disease affects the prognosis of patients with metastatic breast cancer
... of progressive disease (an increase in the size of pre-existing lesions or the appearance of new lesions) should be taken into account when progression-free sur- vival (PFS) is used as the endpoint of a ...
6
Glomerular abundance of complement proteins characterized by proteomic analysis of laser-captured microdissected glomeruli associates with progressive disease in IgA nephropathy
... a progressive versus non-progressive dis- ease ...with progressive versus non-progressive disease Table 5 Glomerular complement protein abundance in IgAN patients according to MEST ...
12
Psychometric validation of the needs assessment tool : progressive disease in interstitial lung disease
... People with interstitial lung disease (ILD) are symptomatic, 1 and have limited disease-modifying treatment options, poor prognosis and poor quality of life. 2 Iden- tification and management of patients’ ...
6
Current Understanding of the Pathogenesis of Progressive Chronic Kidney Disease in Cats
... kidney disease (CKD), the most common histopathological finding is tubulointerstitial inflammation and ...stable disease for many years, some cats show overtly progressive ...
65
Elevated interleukin 12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy
... of progressive MS patients with or without immunosuppressive ...to disease activity in patients with progressive disease, and that a decrease in IL-12 production with an increase in Th2 ...
9
INVOLVEMENT OF GENES IN ALZHEIMER’S DISEASE: OUTLINE AND CONTEMPORARY PERSPECTIVE
... Alzheimer’s disease is one of the most common neurodegenerative brain disease which is the most prevalent cause of dementia ...and progressive impairment of episodic memory resulting from the ...
36
Characteristics and treatment of new onset arthritis after checkpoint inhibitor therapy
... rheumatic disease (patients 3 and 7; mother with rheumatic disease, entity not known) but none of the patients had a personal history of rheumatic or autoimmune ...stable disease, 2/14 (14%) had a ...
7
A randomised study of carboplatin vs sequential ifosfamide/carboplatin for patients with FIGO stage III epithelial ovarian carcinoma
... Seven of 15 patients with progressive disease, and nine of 20 patients with stable disease at the initial response evaluation, following three cycles of ifosfamide, subsequently responde[r] ...
5
Gemcitabine combined with oxaliplatin in pretreated patients with malignant pleural mesothelioma: an observational study
... stable disease (SD), and progressive disease (PD)) and disease control rate (CR+PR+SD), secondary end- points were: overall survival (OS), which was defined as time from first diagnosis of MPM ...
7
Desmoid type fibromatosis of the head and neck in children: a case report and review of the literature
... The disease condition was identified in 126 of the 140 patients ...of disease (NED). Stable disease (SD), partial response (PR), progressive disease (PD), and death occurred in 15, 6, ...
8
iRECIST: how to do it
... tumor disease or clinically sus- pected ...frequent progressive disease and to be able to initiate an early modification of the tumor therapy before the patient may no longer tolerate it due to a ...
7
Functional polycystin 1 dosage governs autosomal dominant polycystic kidney disease severity
... in disease, but the available data are limited and somewhat contradictory ...mild disease in old age, while conditional models do not reflect the disease devel- opment in human ADPKD due to the loss ...
18
Early onset of hypertension and serum electrolyte changes as potential predictive factors of activity in advanced HCC patients treated with sorafenib: results from a retrospective analysis of the HCC-AVR group
... or last follow-up visit. OS was defined as the time-interval between the start of sorafenib therapy and death from any cause or last follow-up visit. PFS, OS and their two-sided 95% confidence intervals (95% CI) were ...
9
Screening of Maize Genotypes/Hybrids for Identifying Resistant Sources against Banded Leaf and Sheath Blight (BLSB) in Rampur, Chitwan, Nepal
... Rijal TR, Paudel DC, Tripathi N. (2007). Screening of maize inbreds/hybrids against banded leaf and sheath blight disease. Pp. 268-270. In: D.B. Gurung, D.C. Paudel, G. KC, S.R. Upadhyay & B.B. Pokharel ...
5
ENZYMES AS DRUGS: A NOVEL THERAPEUTIC APPROACH
... recessive disease caused by deficiency of the lysosomal enzyme ...by progressive accumulation of glycosaminoglycans in nearly all cell types, tissues and ...severe disease have survived into their ...
8
An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort study
... 106 patients with an MDT-confirmed diagnosis of IPF were included in the discovery analyses. Of the remaining 252 eligible subjects recruited to PROFILE Central England 206 had a confirmed diagnosis of IPF and were ...
28
LIMB-GIRDLE MUSCULAR DYSTROPHY: ITS LARGER SIGNIFICANCE
... Primary muscle disease is the most fre- quent cause of progressive muscular weak-. ness in children with neuromuscular disor-[r] ...
5
Metastatic renal medullary carcinoma: response to chemotherapy and unusual long survival
... non-metastatic disease underwent surgical ...metastatic disease was limited to 4.7 months. Indeed, in our patient the disease relapsed within 4 months from date of radical ...
5
Urinary neopterin: An inflammatory marker of disease activity in multiple sclerosis.
... of disease activity but have not proved useful as surrogate markers of disease ...the disease process - an approach which has proved partially successful in EAE (Yednock et ...
356